ATF6 and diabetic kidney disease: Another interesting study reports that the ATF6 pathway of the UPR is inhibited and the IRE1 pathway is activated resulting in sXBP1 activation under normal conditions while the lack of insulin promotes the ATF6‐mediated activation of CHOP that could lead to cell death in diabetic nephropathy (DN).90